Chacruna Institute for Psychedelic Plant Medicines is a registered California 501(c)(3) non-profit organization (EIN 84-3076078). We are a community-oriented organization run by a small staff of experts and enthusiastic volunteers who work to bring education and cultural understanding about psychedelic plant medicines to a wider audience. We promote a bridge between the ceremonial use of sacred plants and psychedelic science and envisage a world where plant medicines and other psychedelics are preserved, protected, and valued as part of our cultural identity and integrated into our social, legal, and health care systems.
Help us to achieve our mission! From our beginnings in 2017, we have stood apart from other psychedelic education and advocacy organizations by pioneering initiatives that support and provide a platform for diverse voices, including women, queer people, people of color, Indigenous people, and the Global South. In efforts to address the lack of diverse representation in the expanding psychedelic landscape, we centered our mission around the empowerment of marginalized voices to foster cultural and political reflections on topics like race, gender, and sexuality in psychedelic science. We believe now more than ever, given the current social and political climate, our work is critical to the future of psychedelic healing for humanity.
Please become a member so that you are able to help Chacruna, yourself, and the world. Support of any amount helps this cause and allows us to provide psychedelic education to anyone who wants to access it.
Anyone who ever drank ayahuasca, or read something about it, knows that it affects visual perception, consciousness, and memory. But have you ever thought...
The relationship between the placebo and psychedelic research is complicated by the psychological aspects of psychedelic therapy. Looking specifically at MDMA trials, Katherine Hendy outlines the history of double-blind studies, how MAPS used placebos in their MDMA trials, and the problems associated with this research methodology.
This articles highlights conservation issues around Tabernanthe iboga, sacred plant medicine of the Bwiti and a common source of ibogaine used in the treatment of addictions.
In a survey published in 2021, Brazil ranked third place in recent high-impact biomedical studies with psychedelics, mainly because of ayahuasca research initiated in the 1990s. However, clinical experimenters and humanities scholars still go their separate ways, without much cross-pollination between the two fields. They are in a unique position, though, to join forces and go beyond the narrow medicalization paradigm underpinning the psychedelic renaissance.
While there has been very promising evidence of safety and effectiveness for psychedelics after a few acute macrodoses in clinical trials, the risks and...
CBD (cannabidiol) oil cures depression. CBD can treat schizophrenia. Everyone sleeps better on CBD. CBD oil really seems to help reduce anxiety. I do...
The rise in popularity of peyote has unfortunately led to overharvesting which consequently poses a great risk for the future of the species. With the increasing need to protect peyote, synthetic mescaline may offer an alternative gateway into this experience that is bereft of issues regarding sustainability. This article summarizes the chemical composition and production of synthetic mescaline.